Pantoprazole sodium and Hypervigilance - a phase IV clinical study of FDA data
Summary:
Hypervigilance is reported as a side effect among people who take Pantoprazole sodium (pantoprazole sodium), especially for people who are male, 60+ old, also take Vitamin D3, and have Major depression.
The phase IV clinical study analyzes which people have Hypervigilance when taking Pantoprazole sodium. It is created by eHealthMe based on reports of 66,361 people who have side effects when taking Pantoprazole sodium from the FDA, and is updated regularly.
What is Pantoprazole sodium?
Pantoprazole sodium has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 66,892 Pantoprazole sodium users. Check the latest studies of Pantoprazole sodium.
What is Hypervigilance?
Hypervigilance is found to be associated with 131 drugs and 288 conditions by eHealthMe. Check the latest studies of Hypervigilance.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
66,361 people reported to have side effects when taking Pantoprazole sodium.
Among them, 14 people (0.02%) have Hypervigilance.

Among these 14 people:
What is the gender of people who have Hypervigilance when taking Pantoprazole sodium? *
- female: 40 %
- male: 60 %
What is the age of people who have Hypervigilance when taking Pantoprazole sodium? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
What are other drugs people take besides Pantoprazole sodium? *
- Vitamin D3: 6 people, 42.86%
- Cymbalta: 5 people, 35.71%
- Besremi: 5 people, 35.71%
- Vitamin D2: 5 people, 35.71%
- Vitamin C: 5 people, 35.71%
- Valsartan: 5 people, 35.71%
- Aspirin: 5 people, 35.71%
- Hydrea: 5 people, 35.71%
- Atorvastatin Calcium: 5 people, 35.71%
- Hydroxyurea: 5 people, 35.71%
What are other side effects people have besides Hypervigilance? *
- Muscle Spasms (muscle contraction): 8 people, 57.14%
- Weight Decreased: 7 people, 50.00%
- Feeling Abnormal: 6 people, 42.86%
- Nausea (feeling of having an urge to vomit): 6 people, 42.86%
- Nausea And Vomiting: 6 people, 42.86%
- Malaise (a feeling of general discomfort or uneasiness): 5 people, 35.71%
- Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur): 5 people, 35.71%
- Insomnia (sleeplessness): 5 people, 35.71%
- Mania (a state of abnormally elevated or irritable mood): 5 people, 35.71%
- Headache (pain in head): 5 people, 35.71%
What are the existing conditions these people have? *
- Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 5 people, 35.71%
- Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 5 people, 35.71%
- Incontinence (lack of moderation or self-control): 3 people, 21.43%
- Nausea And Vomiting: 2 people, 14.29%
- Stress And Anxiety: 1 person, 7.14%
- Rickets (softening of bones): 1 person, 7.14%
- Multiple Allergies (allergy to multiple agents): 1 person, 7.14%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 7.14%
- High Blood Cholesterol: 1 person, 7.14%
- Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Pantoprazole sodium and have Hypervigilance?
- Check whether Hypervigilance is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Pantoprazole sodium:
- Pantoprazole sodium (66,892 reports)
Hypervigilance treatments and more:
- Hypervigilance (1,153 reports)
How severe was Hypervigilance and when was it recovered:
Expand to all the drugs that have ingredients of pantoprazole sodium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Pantoprazole sodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hypervigilance:
- Hypervigilance (131 drugs)
Browse all the conditions that are associated with Hypervigilance:
- Hypervigilance (288 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on pantoprazole sodium (the active ingredients of Pantoprazole sodium) and Pantoprazole sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Vancomycin and Femara - 13 seconds ago
- Harvoni and Sweat - Cold for Men aged 60+ - 14 seconds ago
- Harvoni and Cold Sweat for Men aged 60+ - 15 seconds ago
- Harvoni and Clammy Skin for Men aged 60+ - 15 seconds ago
- Harvoni and Skin - Clammy for Men aged 60+ - 15 seconds ago
- Drug interactions of Irinotecan Hydrochloride and Simvastatin - 20 seconds ago
- Bupivacaine and Sevoflurane drug interactions for boys aged 0-1 - 29 seconds ago
- Taxol and Renal Failure Acute for Men aged 50-59 - 29 seconds ago
- Taxol and Renal Failure for Men aged 50-59 - 30 seconds ago
- Taxol and Kidney Failure for Men aged 50-59 - 30 seconds ago